A shadow economy for unapproved slimming drugs is being driven by social media fitness personalities and sellers on messaging platforms, based on new investigations.
Investigational Drug Gaining Traction Via Social Media
The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its alleged weight-reducing effects. Followers are encouraged to message these profiles privately for supplier links, while also obtaining discount codes.
Active Trade on Messaging Platforms
Additionally, a flourishing market exists on Telegram, where communities with thousands of members share “before and after” photos, injection guides and claims of rapid British shipping. Vendors promote the substance there before redirecting customers to WhatsApp for purchases.
Understanding The Experimental Drug
This medication is an investigational injectable developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could assist individuals lose up to a quarter of their body weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.
Medical Experts Express Worries
However, doctors and chemists have cautions that the distribution of what remains an unapproved drug in the UK is worrisome and could lead to users injecting products of unknown origin.
Several professionals said the demand for the experimental drug could be linked to the increasing price of approved weight loss products such as Mounjaro.
Legal Position and Implementation
Marketing the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unlicensed medication that cannot be marketed or distributed for human use under the Human Medicines Regulations 2012.
Some content creators attempt to sidestep the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still breach medicines, advertising, and customer laws, potentially leading to penalties, legal action or prison.
Service Response and Content Elimination
According to TikTok, the service has removed problematic content and banned related keywords and query recommendations. The company stated it was committed to keeping the platform safe and investing in enhancing enforcement strategies.
Digital Trading Operations
Research also found communities with up to nine thousand participants marketing retatrutide using the platform's built-in search feature, which operates like a public directory. Entering “retatrutide” instantly displays groups with numerous of users, populated with photos of slimming results, glowing reviews and step-by-step instructions for mixing or injecting at residence.
Within minutes of joining one community, a seller posted contact information, where most purchases occur. The vendor sent an instruction manual and promised delivery within 48 hours. When asked whether the substance was authentic, one vendor said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. None inquired about body mass, health issues or past usage.
Item Details and Pricing
Inside these communities, messages display dark colored parcels with Royal Mail labels, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Buyers can select between powder vials, prepared at residence with purified liquid, or ready-to-use pens usually sold at £160 for 20mg. When asked how long a pen should be used, sellers give contradictory answers varying between a few weeks to “depends on your body”.
Service Moderation and Security Measures
A representative for Telegram stated it actively moderated harmful material on its platform including content that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Cautions
“Individuals are injecting materials they can’t verify. Even if the research behind retatrutide is valid, these digital products may not contain what they advertise,” stated a pharmacy expert, the director of pharmacy at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor linked the increase in demand to current cost increases for approved slimming drugs such as Mounjaro. “With prices rising, individuals are turning to social media. But fake treatments are highly risky. You cannot know what’s inside or whether the conditions they were made in was clean,” she said.
Her staff has previously seen patients injured by personal administration from unconfirmed sources. “We recognize the disappointment, but buying from messaging apps or WhatsApp is taking chances with your health,” said the doctor. “These materials could be contaminated or incorrectly dosed.”
Producer Position
A spokesperson from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been reviewed or approved by any government authority anywhere in the world. “Therefore at this point no one can market [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a Lilly investigational substance not yet authorized … may expose patients to possibly serious medical dangers”.
